About Hannah Silver

Hannah is a Senior Account Executive, Health Affairs, in our New York office.

Author Archive | Hannah Silver

The Unseen Innovators: Why ASCO is More Relevant Than Ever

The American Society of Clinical Oncology (ASCO) annual meeting occurs every June and brings together the world’s best minds and latest breakthrough research in cancer. For the past couple of meetings, immunotherapies, drugs that help the immune system combat cancer, have stolen the show. First available to patients in 2011, they began to draw a larger swath of attention in 2014 with two additional market entrants that Forbes called the most important new drugs of that year. While they have and will continue to garner much attention this year, emerging types will steal the headlines, such as chimeric antigen receptor-T (CAR-T) therapies, in which cancer cells are removed from the patient, re-engineered and then re-implanted to attack other cancer cells. Some CAR-Ts are showing almost unbelievable results and changing the future of treatment for some cancers.

Continue Reading